The most important scientific papers which disclose the bad science behind the Oxitec GMO mosquito experiment.
This is the final FDA Environmental Assessment of the proposed GMO mosquito test in the Florida Keys. It presents the most damning evidence directly from the product manufacturer, Oxitec, including the large amount of released females, the high survival rates of “sterile” offspring, and the dangerous lack of testing of the effects on humans and the environment.
In this leaked confidential memo, Oxitec product manager Derric Nimmo outlines the risk of tetracycline contamination in the laboratory and shows that 15% of GMO mosquitoes can survive and reproduce in the wild if they have access to common pet foods.
This study by a Japanese university demonstrates that GMO mosquitoes using the same technology as Oxitec’s can be deployed as a “syringe” to inject viruses into humans for the purpose of mass inoculations.
This official document from the World Health Organization describes the ethical, legal, and medical obligations which private companies and governments face when considering the release of GMO mosquitoes. Oxitec has not complied with any of the testing or informed consent requirements which the document describes.
Oxitec’s study in the Grand Cayman is often cited for its “80%” reduction rate in wild mosquito populations. This paper by Oxitec product manager Derric Nimmo explains how the tests were performed, revealing how poorly the test was constructed and how little it represents real world conditions. After the mosquito releases were discontinued, the environment was not studied for mosquito suppression or for other environmental impacts.
On August 30th, the EPA approved a University of Kentucky test of the safer, non-GMO Wolbachia mosquito which uses a bacterial infection to induce sterility and long-term reduction in mosquito populations. The test can take place in the Florida Keys over two six-month periods in 2016 and 2017.
This recently-revealed document which Oxitec submitted to the Grand Cayman government, shows that company is aware that GMO Aedes aegypti mosquitoes will cause a rise in the competing Asian Tiger species, Aedes albopictus, which also carries disease and is more difficult to combat. The company plans to release GMO Asian Tigers concurrently to combat the problems of the first GMO species.